<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>244181</rcn>
  <id>190143893</id>
  <acronym>PAH-Advance</acronym>
  <teaser><![CDATA[ATXA Therapeutics has developed NTP42, a disruptive new drug for pulmonary arterial hypertension (PAH) and related cardiopulmonary (heart & lung) diseases. NTP42 blocks the thromboxane receptor, a target at the root cause of PAH & related diseases. By treating all clinical...]]></teaser>
  <objective><![CDATA[ATXA Therapeutics has developed NTP42, a disruptive new drug for pulmonary arterial hypertension (PAH) and related cardiopulmonary (heart & lung) diseases. NTP42 blocks the thromboxane receptor, a target at the root cause of PAH & related diseases. By treating all clinical hallmarks in both the LUNGS and HEART, NTP42 offers a game-changing solution for PAH leading to its rapid adoption once marketed. ATXAs Phase I clinical trial showed NTP42 is safe & highly efficacious in man.

With EIC Blended Finance and VC co-investment, ATXA will undertake a Phase II trial on NTP42 in PAH. We will then secure a licensing deal with a pharma to ACCELERATE NTP42 to the PAH market (sales >$1B at 5 yrs post-launch & royalty returns to ATXA). With the proceeds of the licensing deal, we will DIVERSIFY uses of NTP42/pipeline drugs to treat other priority target diseases. This will also ENABLE growth (>100 FTEs), transforming ATXA into a major European pharma with a diversified diseases & drugs portfolio.]]></objective>
  <title>PAH-ADVANCE: Accelerating the Clinical Path of NTP42, a disease-modifying drug that will disrupt the future treatment of cardiopulmonary diseases, including pulmonary arterial hypertension (PAH).</title>
  <totalCost>4181504.25</totalCost>
  <ecMaxContribution>2500000</ecMaxContribution>
  <startDate>2023-01-01</startDate>
  <endDate>2023-12-31</endDate>
  <ecSignatureDate>2022-12-19</ecSignatureDate>
  <duration>12</duration>
  <status>CLOSED</status>
  <identifiers>
    <grantDoi>10.3030/190143893</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2022-12-23 17:02:52</sourceUpdateDate>
  <contentCreationDate readOnly="true">2023-03-07 11:08:35</contentCreationDate>
  <contentUpdateDate>2023-05-24 17:28:21</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-09-19 14:49:09</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>440866</rcn>
        <id>440866-ntp42-a-novel-therapy-for-lung-and-heart-disease</id>
        <title>NTP42 – A novel therapy for lung and heart disease</title>
        <contentUpdateDate>2023-07-25 17:59:03</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode readOnly="true">/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55635</rcn>
        <title>HORIZON-EIC-2022-ACCELERATOR-01</title>
        <identifier>HORIZON-EIC-2022-ACCELERATOR-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55635</rcn>
        <title>HORIZON-EIC-2022-ACCELERATOR-01</title>
        <identifier>HORIZON-EIC-2022-ACCELERATOR-01</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="2500000" terminated="false" sme="true" netEcContribution="2500000" totalCost="4181504.25" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1951806</rcn>
        <id>907542865</id>
        <vatNumber>IE3345642VH</vatNumber>
        <legalName>ATXA THERAPEUTICS LTD</legalName>
        <address>
          <street>TEMPLE CHAMBERS, 3 BURLINGTON ROAD</street>
          <city>Dublin</city>
          <postalCode>D04 RD68</postalCode>
          <country>IE</country>
          <geolocation>53.29417015,-6.1875107</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Dublin</name>
              <rcn>1465443</rcn>
              <nutsCode>IE061</nutsCode>
              <parents>
                <region>
                  <name>Eastern and Midland</name>
                  <rcn>1464994</rcn>
                  <nutsCode>IE06</nutsCode>
                  <parents>
                    <region>
                      <name>Ireland</name>
                      <rcn>305662504</rcn>
                      <nutsCode>IE0</nutsCode>
                      <parents>
                        <region>
                          <name>Ireland</name>
                          <rcn>305826344</rcn>
                          <nutsCode>IE</nutsCode>
                          <euCode>IE</euCode>
                          <isoCode>IE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Ireland</name>
              <rcn>305826344</rcn>
              <nutsCode>IE</nutsCode>
              <euCode>IE</euCode>
              <isoCode>IE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>706909</rcn>
        <id>HORIZON_HORIZON-EIC-2022-ACCELERATOROPEN-01</id>
        <code>HORIZON-EIC-2022-ACCELERATOROPEN-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>EIC Accelerator Open</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456234</code>
              <title>Project financing</title>
              <displayCode readOnly="true">/Project financing</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454386</code>
              <title>Market-creating innovation</title>
              <displayCode readOnly="true">/Market-creating innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450539</code>
              <title>Competitor analysis</title>
              <displayCode readOnly="true">/Competitor analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450029</code>
              <title>Business model innovation</title>
              <displayCode readOnly="true">/Business model innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451698</code>
              <title>Entrepreneurship</title>
              <displayCode readOnly="true">/Entrepreneurship</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453594</code>
              <title>Innovation support services</title>
              <displayCode readOnly="true">/Innovation support services</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457773</code>
              <title>Spin-off companies</title>
              <displayCode readOnly="true">/Spin-off companies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456213</code>
              <title>Product innovation</title>
              <displayCode readOnly="true">/Product innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454395</code>
              <title>Marketing strategy</title>
              <displayCode readOnly="true">/Marketing strategy</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453822</code>
              <title>Investment readiness</title>
              <displayCode readOnly="true">/Investment readiness</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452043</code>
              <title>Feasibility analysis</title>
              <displayCode readOnly="true">/Feasibility analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458031</code>
              <title>Sustainable innovation</title>
              <displayCode readOnly="true">/Sustainable innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450041</code>
              <title>Business support services</title>
              <displayCode readOnly="true">/Business support services</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458163</code>
              <title>Technological innovation</title>
              <displayCode readOnly="true">/Technological innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457365</code>
              <title>SME support</title>
              <displayCode readOnly="true">/SME support</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456414</code>
              <title>Public sector innovation</title>
              <displayCode readOnly="true">/Public sector innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456186</code>
              <title>Private investment</title>
              <displayCode readOnly="true">/Private investment</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453576</code>
              <title>Innovation management</title>
              <displayCode readOnly="true">/Innovation management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450521</code>
              <title>Company valuation</title>
              <displayCode readOnly="true">/Company valuation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452100</code>
              <title><![CDATA[Financial & Investment management]]></title>
              <displayCode readOnly="true"><![CDATA[/Financial & Investment management]]></displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451181</code>
              <title>Due diligence</title>
              <displayCode readOnly="true">/Due diligence</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451088</code>
              <title>Disruptive innovation</title>
              <displayCode readOnly="true">/Disruptive innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458202</code>
              <title>Technology management</title>
              <displayCode readOnly="true">/Technology management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450026</code>
              <title>Business management</title>
              <displayCode readOnly="true">/Business management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450017</code>
              <title>Business development</title>
              <displayCode readOnly="true">/Business development</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458661</code>
              <title>Venture capital</title>
              <displayCode readOnly="true">/Venture capital</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450014</code>
              <title>Business coaching and mentoring</title>
              <displayCode readOnly="true">/Business coaching and mentoring</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456756</code>
              <title>Risk management</title>
              <displayCode readOnly="true">/Risk management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453837</code>
              <title>IPR management</title>
              <displayCode readOnly="true">/IPR management</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1189804</rcn>
        <id>190143893_14844_PUBLIHORIZON</id>
        <title>A Phase I Clinical Trial Assessing the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of NTP42:KVA4, a Novel Thromboxane Receptor Antagonist, in Healthy Subjects</title>
        <details>
          <authors>Kinsella BT, Reid HM, Mulvaney EP, Boyce M, Yamaoto T, Maginn M, Perkins C</authors>
          <journalNumber>207</journalNumber>
          <journalTitle>American Journal of Respiratory and Critical Care Medicine</journalTitle>
          <publishedPages/>
          <publishedYear>2023</publishedYear>
          <publisher>American Thoracic Society</publisher>
        </details>
        <identifiers>
          <doi>10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A3780</doi>
          <issn>1535-4970</issn>
        </identifiers>
        <sourceUpdateDate>2024-01-25 07:46:10</sourceUpdateDate>
        <contentUpdateDate>2024-12-12 09:19:06</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/CONFERENCE_PROCEEDING</code>
              <title>Conference proceedings</title>
              <displayCode readOnly="true">/Conference proceedings</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1036401</rcn>
        <id>190143893_12802_PUBLIHORIZON</id>
        <title>Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial</title>
        <details>
          <authors>Reid HM, Maginn M, Perkins CM, Mulvaney EP, Boyce M, Yamamoto T, Kinsella BT</authors>
          <journalNumber/>
          <journalTitle>Frontiers in Pharacology</journalTitle>
          <publishedPages/>
          <publishedYear>2023</publishedYear>
          <publisher>Frontiers Media S.A.</publisher>
        </details>
        <identifiers>
          <doi>10.3389/fphar.2023.1296188</doi>
          <issn>1663-9812</issn>
        </identifiers>
        <sourceUpdateDate>2024-01-25 07:46:10</sourceUpdateDate>
        <contentUpdateDate>2024-01-29 11:30:03</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode readOnly="true">/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1054261</rcn>
        <id>190143893_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - PAH-Advance (PAH-ADVANCE: Accelerating the Clinical Path of NTP42, a disease-modifying drug that will disrupt the future treatment of cardiopulmonary diseases, including pulmonary arterial hypertension (PAH).)</title>
        <teaser>Pulmonary arterial hypertension (PAH) is characterized by high blood pressure in the lungs due to obstruction of small lung arteries. The reduced blood flow makes it harder for the right side of the heart to pump blood to the lungs, leading to heart failure. While the current...</teaser>
        <description>periodic</description>
        <sourceUpdateDate>2024-03-08 21:46:08</sourceUpdateDate>
        <contentUpdateDate>2024-03-13 09:52:14</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode readOnly="true">/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <webItem source="corda" type="relatedResultAttachment">
              <language>en</language>
              <availableLanguages readOnly="true">en,any</availableLanguages>
              <uri>/docs/results/horizon/190143/190143893_PS/pah-advance-graphic-19jan24.jpg</uri>
              <alternativeText><![CDATA[Overview of ATXA's PAH-Advance Program]]></alternativeText>
              <mimetype readOnly="true">image/jpeg</mimetype>
              <size readOnly="true">148480</size>
            </webItem>
          </associations>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-EIC-ACC-BF</code>
        <title>HORIZON EIC Accelerator Blended Finance</title>
        <description>HORIZON EIC Accelerator Blended Finance</description>
        <displayCode readOnly="true">/HORIZON EIC Accelerator Blended Finance</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
